Of the 24 strains of Bordetella pertussis examined, 2 produced bacteriocins that inhibited the growth of all but 2 other strains of this species. The two strains producing the bacteriocin and the two resistant strains were rough, whereas all susceptible strains were smooth. The bacteriocin was not active on the B. parapertussis or B. bronchiseptica strains tested. These bacteriocins appeared to be protein in nature, since they were heat-labile and partially inactivated by trypsin. They were antigenic but the neutralizing antibodies did not precipitate the antigens. Absorption of the antiserum with homologous cell suspensions removed the agglutinating, but not the neutralizing, antibody.
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A substance produced by Escherichia coli which inhibited only related organisms was first described by Gratia (7) ; the term colicin was later applied to this material (4) . The inhibitory characteristic has been investigated in other families of bacteria, and there are now 15 known groups of bacteriocins (14) .
Jacob et al. (11) advanced the following definition. "Bacteriocins are protein-like substances whose activity is restricted to related species and whose activity is conditioned by the presence of specific receptors. Their biosynthesis is associated with a lethal consequence for the producing organisms."
During a survey for phage of Bordetella pertussis, an inhibitory substance resembling a bacteriocin was observed. Since a Bordetella bacteriocin had not been previously described, the nature of this substance was investigated.
MATERIALS AND METHODS
Organisms. Strains (15) , whereas other strains were smooth, virulent organisms in phases 1 to 3.
Survey techniques. Two survey techniques were used with Bordet Gengou Broth Base (BG, Difco), containing 2% agar, 6 ml of glycerol (Baker-analyzed reagent) per 1,000 ml ofbroth, and 20% citrated whole human blood serving to support growth. In the spot technique, a heavy loopful of the strain being tested was spotted on a base culture of an indicator strain which had been applied in an even layer with a sterile swab. The plates were incubated for 48 hr at 37 C.
By use of the perpendicular streak technique developed by Fredericq (4) for colicin survey, a streak of the test strain was made with a sterile swab across a plate of BG and the plate was incubated for 48 hr at 37 C. At this time, streaks of indicator strains were made perpendicular to the original streak. The plates were incubated another 48 hr and checked for lysis.
Ultraviolet irradiation was attempted to induce the production of the bacteriocin. Cultures (48-hr) BACTERIOCIN PRODUCED BY BORDETELLA PERTUSSIS assayed into the well. The plates were incubated at 37 C for 48 hr. The entire zone of lysis was measured, 11 mm of the well was subtracted, and the remainder was divided by 2. A 2-mm zone was arbitrarily chosen as an end point and was designated as 1 unit of activity. A serial twofold dilution of the extract was made in saline, and each dilution was tested. The reciprocal of the dilution that showed 1 unit of activity was taken as the titer of the preparation.
Methodsfor determination ofprotein. A modification of the Folin-Wu method (13) was used for the measurement of protein in the samples obtained during the various stages of purification of the bacteriocin. Crystalline bovine albumin served as the standard.
The protein content of the fractions obtained during chromatography was estimated according to Kalckar's (12) variation of the method developed by Warburg and Christian (17) . The same molarity of buffer which was used to obtain the fraction was used as a blank for that fraction.
Cell density determination. The cells were diluted in saline, and the optical density (OD) was read at 575 m,u on a Coleman Junior spectrophotometer. An OD of 0.30 equalled a viable-cell count of 2.2 X 109 cells per milliliter.
Production and concentration of the bacteriocin.
Dialyzed Brain Heart Infusion (BHI, Difco) was used for the production of the bacteriocin of B. pertussis 190 and 6627. A 37-g amount of BHI was dissolved in 100 ml of distilled water and dialyzed overnight at 4 C against 400 ml of distilled water. The dialysate was replaced with 200 ml of distilled water, and dialysis was continued overnight. An addition of 1% agar was made to the combined dialysates, which were then autoclaved and distributed in 50-ml amounts into large petri plates (150 X 20 mm). The plates were inoculated with 2 drops of heavy cell suspension, incubated at 37 C for 24 hr, placed in a freezer (-20 C) for 48 hr, and thawed at 37 C, followed by removal of the fluid from the collapsed agar by centrifugation at 10,000 X g for 50 min at 4 C. over a period of 3 weeks. The bacteriocin used for all injections was partially purified by chromatography. The rabbits were bled twice during the injections and were exsanguinated 1 week after the final injection. The sera were sterilized by filtration with membrane filters (GS type, Millipore Corp., Bedford, Mass.) and were stored at 4 C. To test for agglutinating antibody, the sera were diluted 1:10, and twofold serial dilutions were made with saline. To 0.5 ml of the diluted sera was added 0.5 ml of cell suspensions of B. pertussis strains 190 or 6627 at a concentration of 9.0 X 108 cells per milliliter (tube no. 3 of the McFarland nephelometer series). Normal rabbit serum was used as a control. After overnight incubation at 37 C, the agglutination titer was determined by recording the highest dilution showing visible agglutination.
Before testing for neutralizing antibody, the sera were heated at 56 C for 1 hr since the unheated serum was inhibitory for the indicator strain, possibly due to complement. After making twofold serial dilutions with saline, an equal amount of bacteriocin containing 128 units was added, and the mixture was incubated at 37 C for 1 hr. An untreated sample of bacteriocin was included as a control.
The cells to be used for absorption were 48-hr cultures of B. pertussis 190 grown on BG. The cells were washed with saline, suspended in 5.0 ml of serum, and heated for 1 hr at 56 C. The cells were then centrifuged at 7,000 X g for 30 min, and the serum was removed and tested for agglutinating antibody. This procedure was repeated four times; the neutralizing antibody titer was checked after the second and fourth absorptions.
RESULTS
By use of both the spot and streak techniques, B. pertussis strains 190 and 6627 were inhibitory to all other strains of B. pertussis except strains 9306, 10390, and 11615. The results of a typical experiment are shown in Fig. 1 . Both producing strains were resistant to the bacteriocins. At no time did these two strains show any inhibitory effect on strains of B. parapertussis or B. bronchiseptica.
Of the strains exposed to ultraviolet light, no new bacteriocinogenic strains were found, nor were the spectra of the bacteriocinogenic cultures increased after ultraviolet irradiation.
After The bacteriocinic activity obtained with liquid BHI aerated on a shaker was less than that obtained with solid media. Two types of cell disruption, sonic treatment and amyl alcohol-chloroform treatment, were unsuccessful in attempts to increase the titer.
There was some absorption of the bacteriocin with the sintered-glass filter used for sterilization.
The pattern of protein distribution and activity after chromatography is shown in Fig. 2 . The peak of activity in the 1.0 M fraction did not coincide with the protein peak for that fraction. As shown in Table 2 , the purification was fourfold since the activity increased from 30 to 120 units per mg of protein.
The bacteriocin did not diffuse through cellophane. Heating at 56 C for 30 min produced no loss of activity, whereas heating at 65, 75, and bActivity of the original supernatant fluid was less than 1 unit per ml. It was estimated to be about 0.75 unit per ml after concentration.
100 C produced a loss of approximately 85% of the activity in all three cases. The activity of the bacteriocin was destroyed at extreme pH values at 37 C; only residual activity remained after 24 hr of exposure to pH 3, 4, 9, and 10 and readjustment of the pH to 7.0 for testing. It was more stable near a neutral pH; by the 7th day, 75 to 80% of the activity had been destroyed.
Trypsin only partially inactivated the bacteriocin, with 33% being destroyed. There was no difference in the loss of activity in the 1-and 3.5-hr exposures. Neither ribonuclease nor deoxyribonuclease had any effect on the activity of the bacteriocin. The bacteriocin was stable at -70 C. and no loss of activity was noted after lyophylization.
Intraperitoneal injection of the bacteriocin (25.6 units in 0.2 ml) into mice produced no ill effect, and intradermal injection of 1.6 units in 0.2 ml in rabbits failed to produce any skin lesion. It appeared that this bacteriocin was nontoxic.
The final agglutinating titer of the antiserum prepared against the extract of strain 190 was 20,480 for the cells of the homologous strain and 2,560 for the cells of strain 6627. A 0.5-ml amount of a 1:256 dilution of the same antiserum completely neutralized 128 units of the homologous bacteriocin, whereas the same serum neutralized 128 units of bacteriocin of strain 6627 at a 1:64 dilution. After the four absorptions with cells of strain 190, the agglutinating titer was reduced from 20,480 to 640 (32-fold decrease). The neutralizing antibody titer was reduced from 256 to 128 (twofold decrease).
In the agar gel diffusion experiments, multiple lines of precipitation were formed with the un- treated antiserum and the antiserum precipitated with 33% ammonium sulphate. However, there were no lines of precipitation with the normal or the absorbed serum.
DIscUSSION
The spectrum of the bacteriocin produced by two strains of B. pertussis was limited to other strains of B. pertussis and had no inhibitory effect on B. parapertussis or B. bronchiseptica. The two producing strains were resistant to the bacteriocins.
Compared with some other bacteriocins investigated, the number of bacteriocinogenic strains of Bordetella is relatively low. Only 2 of the 24 strains tested produced the bacteriocin, and these had the same activity spectrum. In the work with Pasturella, for example, 23 of 24 strains of P. pestis were found to produce pesticin (2) .
It was also noted that the two strains producing the bacteriocin were rough; they were neither mouse-virulent nor dependent upon the presence of blood for growth. The two strains of B. pertussis which were resistant to the bacteriocin were also rough, whereas all the susceptible strains were smooth.
These observations suggest that specific receptors may be necessary for attachment, and only the smooth strains possess these receptors. The bacteriocin may be a part of the somatic antigen of the cell which is not incorporated into the rough strains owing to some defect of synthetic mechanism. Colicin K (5, 6, 16) and colicin V (9) have been purified and found to be a part of the somatic antigen of the producing organism.
The proteinaceous nature of the bacteriocin produced by Bordetella was demonstrated by the following studies: precipitation by ammonium sulfate, partial inactivation by trypsin, and inactivation by incubation at 65 C and above.
Two types of antibody, agglutinating and neutralizing, were produced after injections of partially purified extracts of B. pertussis 190. After absorption of the agglutinating antibody with cells of strain 190, the neutralizing antibody was still active but did not precipitate with the antigen. This observation is similar to that of Amano et al. (1) , who found that antiserum to colicin K contained both a precipitating and a nonprecipitating antibody, the latter being the neutralizing antibody.
There was moderate cross-reaction of the antiserum of the bacteriocin of strain 190 with the bacteriocin of strain 6627. There was also agglutination of the cells of 6627 but to a lesser extent. This indicates that the bacteriocins are serologically related but not identical-at least not in the partially purified stage. In the study of the antigenic relationships of bacteriocins within other species, there was no cross-reaction within megacins (10) but complete cross-reaction within monocins (8). 
